MYGN
$4.80+0.05 (+1.05%)
Market ClosedLast close May 1
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests.
$4.80+0.05 (+1.05%)
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests.